Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
April 4, 2019 Off

GlycoMimetics to Present at Upcoming Investor Conferences

By BusinessWire

ROCKVILLE, Md.–(BUSINESS WIRE)–GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that senior management will present corporate updates at two upcoming investor conferences…

Myriad Genetics, AstraZeneca, Merck expand collaboration, using BRACAnalysis CDx to identify germline BRCA in men with mCRPC cancer
April 4, 2019 Off

Myriad Genetics, AstraZeneca, Merck expand collaboration, using BRACAnalysis CDx to identify germline BRCA in men with mCRPC cancer

By Dino Mustafić

Myriad Genetics, AstraZeneca, and Merck have expanded their companion diagnostic collaboration, to use BRACAnalysis CDx to identify germline BRCA mutations in…

April 4, 2019 Off

4th World Congress on Interventional Therapies for Type 2 Diabetes Focuses on Barriers to Utilization of Bariatric/Metabolic Surgery and Hosts the First-Ever Joint Consensus Conference on Obesity & Diabetes Stigma

By BusinessWire

45 Leading Global Societies and 90 World-Renowned Experts to Gather in New York City at the 4th World Congress on…

U.S. FDA Approves IBRANCE for the Treatment of Men with HR+, HER2- Metastatic Breast Cancer
April 4, 2019 Off

U.S. FDA Approves IBRANCE for the Treatment of Men with HR+, HER2- Metastatic Breast Cancer

By BusinessWire

Approval of expanded indication based predominately on real-world data NEW YORK–(BUSINESS WIRE)–Pfizer (NYSE:PFE) today announced that the U.S. Food and…

AMPLEXOR Releases VigilanceExpertTM 5.0 to Harmonize and Standardize Processes in Pharmacovigilance Information Management
April 4, 2019 Off

AMPLEXOR Releases VigilanceExpertTM 5.0 to Harmonize and Standardize Processes in Pharmacovigilance Information Management

By BusinessWire

New module available as a standalone solution or fully integral with AMPLEXOR’s Life Sciences Suite BROOMFIELD, Colo.–(BUSINESS WIRE)–The Life Sciences…

HepQuant’s Disease Severity Index (DSI) Demonstrates Hepatic Functional Improvement in High Percentage of NASH Patients Treated with Obeticholic Acid: Results from INTERCEPT 747-117
April 4, 2019 Off

HepQuant’s Disease Severity Index (DSI) Demonstrates Hepatic Functional Improvement in High Percentage of NASH Patients Treated with Obeticholic Acid: Results from INTERCEPT 747-117

By BusinessWire

The First HepQuant SHUNT™ Data From An Interventional Drug Study in NASH DENVER–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/NASH?src=hash” target=”_blank”gt;#NASHlt;/agt;–HepQuant, LLC, a Greenwood Village,…

April 4, 2019 Off

Global Next Generation Sequencing (NGS) Market Outlook Study, 2019 to 2027 – Increasing Adoption in Clinical Workflows – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Next Generation Sequencing Market Analysis & Trends – Industry Forecast to 2027” report has been added to…

April 4, 2019 Off

Drug Delivery Technologies: Worldwide Market Analysis 2015-2018 and Forecast 2019-2027 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Drug Delivery Technologies Market Analysis & Trends – Industry Forecast to 2027” report has been added to…

April 4, 2019 Off

Congresswoman Dingell Honored as Innovator in Biotechnology

By BusinessWire

WASHINGTON–(BUSINESS WIRE)–Congresswoman Debbie Dingell was recognized today by the Biotechnology Innovation Organization (BIO) for her leadership as an Innovator in…

April 4, 2019 Off

VenatoRx Pharmaceuticals Names Lisa Wittmer, Ph.D. Chief Development Officer

By BusinessWire

MALVERN, Pa.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/antibiotics?src=hash" target="_blank"gt;#antibioticslt;/agt;–VenatoRx Pharmaceuticals today announced that Lisa Wittmer, Ph.D. has joined the Company as Chief Development Officer.…

Posts pagination

Previous 1 … 3,300 3,301 3,302 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine